Thursday, October 4, 2018: 2:00 PM-3:15 PM
Room: W 2005-2024
At the conclusion of this session, participants will be able to:
- contrast the advantages and disadvantages of prescribing probiotics for all hospitalized patients who are taking antibiotics
- critically analyze available data suggesting that HIV persons with an undetectable viral load are not infectious to others
- define the risks and benefits of maintaining IV access after hospital discharge in persons known to use illicit IV drugs
Academicians, Clinicians, Fellows, HIV clinicians, HIV specialists, Infectious diseases physicians, Medical students and residents, Members-in-training, Pharmacists
Epidemiology and Infection Control, Pediatric ID, Trainee, Adult ID
Patrick Joseph, MD, FIDSA, FSHEA, University of California, San Francisco
Ann MacIntyre, DO, MHS, Mercy Hospital
Probiotics for ALL in-patients on antibiotics?
“U=U” ? Does HIV Undetectable mean Untransmittable?
PICC lines for IVDU at Discharge. Acceptable or Not?
Maximum of 1.25 hours of AMA PRA Category 1 Credit™
ACPE 1.25 knowledge-based contact hours of pharmacy CE